Nuvation Bio Inc. (NUVB)
NYSE: NUVB · Real-Time Price · USD
6.37
-0.23 (-3.48%)
At close: Aug 11, 2026, 4:00 PM EDT
6.41
+0.04 (0.63%)
After-hours: Aug 11, 2026, 7:59 PM EDT

Nuvation Bio Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
169.962.97.87---
Revenue Growth
1083.56%698.96%----
Gross Profit
9.7753.60.8---
Operating Income
-137.63-213.06-592.63-99.82-119.73-93.32
Net Income
-149.83-204.63-567.94-75.8-104.2-86.85
Earnings Per Share
-0.44-0.60-2.11-0.35-0.48-0.44
EPS Growth
------

Revenue by Geography

Fiscal YearTTMFY 2025FY 2024
Period EndingJun '26 Dec '25 Dec '24
United States
12424.66-
China
16.349.415.15
Japan
29.5628.832.73
Total
169.962.97.87

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
660.96529.21502.69611.21661.01765.39
Total Debt
403.26203.178.924.014.263.06
Net Cash (Debt)
257.69326.04493.78607.21656.75762.34
Net Cash Growth
-36.71%-33.97%-18.68%-7.54%-13.85%253.60%
Net Cash Per Share
0.730.951.842.773.033.85

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-120.52-173.43-130.41-68-96.11-68.19
Capital Expenditures
-0.4-0.35-0.16-0.07-0.37-0.28
Free Cash Flow
-120.93-173.78-130.58-68.07-96.48-68.47
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
5.75%85.22%10.10%---
Operating Margin
-81.00%-338.72%-7527.33%---
Pretax Margin
-88.19%-325.31%-7213.76%---
Profit Margin
-88.19%-325.31%-7213.76%---
FCF Margin
-71.17%-276.27%-1658.52%---

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
13.1649.36114.14---